{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:58:49Z","timestamp":1786978729777,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"value":"9781071639252","type":"print"},{"value":"9781071639269","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3926-9_7","type":"book-chapter","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T13:02:12Z","timestamp":1721653332000},"page":"91-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Guidelines for In Vitro Production and Quantification of Rift Valley Fever Virus"],"prefix":"10.1007","author":[{"given":"Marie-Pierre","family":"Confort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rick","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Ratinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-ento-010715-023819","volume":"61","author":"KJ Linthicum","year":"2016","unstructured":"Linthicum KJ, Britch SC, Anyamba A (2016) Rift Valley fever: an emerging mosquito-borne disease. Annu Rev Entomol 61:395\u2013415. https:\/\/doi.org\/10.1146\/annurev-ento-010715-023819","journal-title":"Annu Rev Entomol"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1051\/vetres\/2010033","volume":"41","author":"M Pepin","year":"2010","unstructured":"Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J (2010) Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res 41:61. https:\/\/doi.org\/10.1051\/vetres\/2010033","journal-title":"Vet Res"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/v3050493","volume":"3","author":"T Ikegami","year":"2011","unstructured":"Ikegami T, Makino S (2011) The pathogenesis of Rift Valley fever. Viruses 3:493\u2013519. https:\/\/doi.org\/10.3390\/v3050493","journal-title":"Viruses"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4269\/ajtmh.2010.09-0293","volume":"83","author":"MK Njenga","year":"2010","unstructured":"Njenga MK, Paweska JT, Lederman ER, Mutonga D, Sharif SK, Anyangu AS et al (2010) Risk factors for severe Rift Valley fever infection in Kenya, 2007. Am J Trop Med Hygiene 83:14\u201321. https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0293","journal-title":"Am J Trop Med Hygiene"},{"key":"7_CR5","doi-asserted-by":"publisher","unstructured":"Reed C, Lin K, Wilhelmsen C, Friedrich B, Nalca A, Keeney A et al (2013) Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development. De Silva AM, editor. PLoS Negl Trop Dis 7: e2156. https:\/\/doi.org\/10.1371\/journal.pntd.0002156","DOI":"10.1371\/journal.pntd.0002156"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4049\/jimmunol.62.2.213","volume":"62","author":"KC Smithburn","year":"1949","unstructured":"Smithburn KC, Mahaffy AF (1949) Rift Valley fever; accidental infections among laboratory workers. J Immunol 62:213\u2013227","journal-title":"J Immunol"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1099\/0022-1317-77-12-3053","volume":"77","author":"A Billecocq","year":"1996","unstructured":"Billecocq A, Vialat P, Bouloy M (1996) Persistent infection of mammalian cells by Rift Valley fever virus. J Gen Virol 77:3053\u20133062. https:\/\/doi.org\/10.1099\/0022-1317-77-12-3053","journal-title":"J Gen Virol"},{"key":"7_CR8","doi-asserted-by":"publisher","unstructured":"Moutailler S, Roche B, Thiberge J-M, Caro V, Rougeon F, Failloux A-B (2011) Host alternation is necessary to maintain the genome stability of Rift Valley fever virus. Rico-Hesse R, editor. PLoS Negl Trop Dis 5: e1156. https:\/\/doi.org\/10.1371\/journal.pntd.0001156","DOI":"10.1371\/journal.pntd.0001156"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/vaccines7030093","volume":"7","author":"C Li","year":"2019","unstructured":"Li C, Widen D, Kaiser W et al (2019) Attenuation of Zika virus by passage in human HeLa cells. Vaccine 7:93. https:\/\/doi.org\/10.3390\/vaccines7030093","journal-title":"Vaccine"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1128\/JVI.00395-15","volume":"89","author":"A Janowicz","year":"2015","unstructured":"Janowicz A, Caporale M, Shaw A, Gulletta S, Di Gialleonardo L, Ratinier M et al (2015) Multiple genome segments determine virulence of bluetongue virus serotype 8. L\u00f3pez S, editor. J Virol 89:5238\u20135249. https:\/\/doi.org\/10.1128\/JVI.00395-15","journal-title":"J Virol"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"14253","DOI":"10.1128\/JVI.79.22.14253-14260.2005","volume":"79","author":"IP Greene","year":"2005","unstructured":"Greene IP, Wang E, Deardorff ER, Milleron R, Domingo E, Weaver SC (2005) Effect of alternating passage on adaptation of Sindbis virus to vertebrate and invertebrate cells. J Virol 79:14253\u201314260. https:\/\/doi.org\/10.1128\/JVI.79.22.14253-14260.2005","journal-title":"J Virol"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","volume":"4","author":"NH Levitt","year":"1986","unstructured":"Levitt NH, Ramsburg HH, Hasty SE, Repik PM, Cole FE, Lupton HW (1986) Development of an attenuated strain of chikungunya virus for use in vaccine production. Vaccine 4:157\u2013162. https:\/\/doi.org\/10.1016\/0264-410X(86)90003-4","journal-title":"Vaccine"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/infdis\/jit546","volume":"209","author":"A Beck","year":"2014","unstructured":"Beck A, Tesh RB, Wood TG, Widen SG, Ryman KD, Barrett ADT (2014) Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing. J Infect Dis 209:334\u2013344. https:\/\/doi.org\/10.1093\/infdis\/jit546","journal-title":"J Infect Dis"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.3390\/v14112470","volume":"14","author":"S Lacote","year":"2022","unstructured":"Lacote S, Tamietti C, Chabert M, Confort M-P, Conquet L, Pulido C et al (2022) Intranasal exposure to Rift Valley fever virus live-attenuated strains leads to high mortality rate in immunocompetent mice. Viruses 14:2470. https:\/\/doi.org\/10.3390\/v14112470","journal-title":"Viruses"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3389\/fimmu.2019.00860","volume":"10","author":"T Chrun","year":"2019","unstructured":"Chrun T, Lac\u00f4te S, Urien C, Richard C-A, Tenbusch M, Aubrey N et al (2019) A DNA vaccine encoding the Gn Ectodomain of Rift Valley fever virus protects mice via a humoral response decreased by DEC205 targeting. Front Immunol 10:860. https:\/\/doi.org\/10.3389\/fimmu.2019.00860","journal-title":"Front Immunol"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","volume":"73","author":"UJ Buchholz","year":"1999","unstructured":"Buchholz UJ, Finke S, Conzelmann K-K (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251\u2013259. https:\/\/doi.org\/10.1128\/JVI.73.1.251-259.1999","journal-title":"J Virol"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-59745-394-3_24","volume-title":"Hepatitis C: methods and protocols","author":"BD Lindenbach","year":"2009","unstructured":"Lindenbach BD, Measuring HCV (2009) Infectivity produced in cell culture and in vivo. In: Tang H (ed) Hepatitis C: methods and protocols. Humana Press, Totowa, pp 329\u2013336. https:\/\/doi.org\/10.1007\/978-1-59745-394-3_24"}],"container-title":["Methods in Molecular Biology","Rift Valley Fever Virus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3926-9_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T13:03:13Z","timestamp":1721653393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3926-9_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071639252","9781071639269"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3926-9_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"23 July 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}